Thérapeutiques anti-oxydantes et anti-AGE : bilans et perspectives
J. Soc. Biol., 195 4 (2001) 391-398
Published online: 2017-04-04
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Exploring Glyoxalase Strategies for Managing Sugar-Induced Chronic Diseases
Alejandro GugliucciLife 15 (5) 794 (2025)
https://doi.org/10.3390/life15050794
Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?
Sangmi S. Park, Jessica L. Perez Perez, Brais Perez Gandara, Christina W. Agudelo, Romy Rodriguez Ortega, Huma Ahmed, Itsaso Garcia-Arcos, Cormac McCarthy and Patrick GeraghtyMedicina 58 (8) 1030 (2022)
https://doi.org/10.3390/medicina58081030
Investigation of a new horizon antifungal activity with enhancing the antimicrobial efficacy of ciprofloxacin and its binary mixture via their encapsulation in nanoassemblies: in vitro and in vivo evaluation
Sally Abou Taleb, Asmaa Badawy Darwish, Amira Abood and Amany M. MohamedDrug Development Research 81 (3) 374 (2020)
https://doi.org/10.1002/ddr.21632
In vitro anti-glycation activity of the marine plant Posidonia oceanica (L.) Delile
Marzia Vasarri, Emanuela Barletta, Matteo Ramazzotti and Donatella Degl’InnocentiJournal of Ethnopharmacology 259 112960 (2020)
https://doi.org/10.1016/j.jep.2020.112960
Annona cherimola Miller Fruit as a Promising Candidate against Diabetic Complications: An In Vitro Study and Preliminary Clinical Results
Marzia Vasarri, Emanuela Barletta, Santina Vinci, Matteo Ramazzotti, Andrea Francesconi, Francesco Manetti and Donatella Degl’InnocentiFoods 9 (10) 1350 (2020)
https://doi.org/10.3390/foods9101350
Metformin and risk of chronic obstructive pulmonary disease in diabetes patients
C.-H. TsengDiabetes & Metabolism 45 (2) 184 (2019)
https://doi.org/10.1016/j.diabet.2018.05.001
Reference Module in Biomedical Sciences
Mohammad Nadeem KhanReference Module in Biomedical Sciences (2019)
https://doi.org/10.1016/B978-0-12-801238-3.11460-6
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Tseng Chin-HsiaoAging and disease 10 (1) 37 (2019)
https://doi.org/10.14336/AD.2017.1202
Perspectives in Environmental Toxicology
Firoz Akhter, Asma Akhter and Saheem AhmadEnvironmental Science and Engineering, Perspectives in Environmental Toxicology 99 (2017)
https://doi.org/10.1007/978-3-319-46248-6_5
https://doi.org/10.1016/bs.podrm.2017.02.003
Nano-Biomaterials For Ophthalmic Drug Delivery
Shruti Hazare, Rongbing Yang, Smita Chavan, Mala D. Menon and Mahavir B. ChouguleNano-Biomaterials For Ophthalmic Drug Delivery 277 (2016)
https://doi.org/10.1007/978-3-319-29346-2_14
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
Parveen Salahuddin, Gulam Rabbani and Rizwan KhanCellular and Molecular Biology Letters 19 (3) (2014)
https://doi.org/10.2478/s11658-014-0205-5
Inhibition of advanced glycation endproduct formation by foodstuffs
Chi-Hao Wu, Shang-Ming Huang, Jer-An Lin and Gow-Chin YenFood & Function 2 (5) 224 (2011)
https://doi.org/10.1039/c1fo10026b
Naturally occurring inhibitors against the formation of advanced glycation end-products
Xiaofang Peng, Jinyu Ma, Feng Chen and Mingfu WangFood & Function 2 (6) 289 (2011)
https://doi.org/10.1039/c1fo10034c
Silymarin: A Novel Antioxidant with Antiglycation and Antiinflammatory PropertiesIn VitroandIn Vivo
Chi-Hao Wu, Shang-Ming Huang and Gow-Chin YenAntioxidants & Redox Signaling 14 (3) 353 (2011)
https://doi.org/10.1089/ars.2010.3134
Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies
M. Daroux, G. Prévost, H. Maillard-Lefebvre, et al.Diabetes & Metabolism 36 (1) 1 (2010)
https://doi.org/10.1016/j.diabet.2009.06.005
A perspective on the role of metals in diabetes: past findings and possible future directions
Jennifer A. Meyer and Dana M. SpenceMetallomics 1 (1) 32 (2009)
https://doi.org/10.1039/B817203J
Naturally occurring flavonoids attenuate high glucose‐induced expression of proinflammatory cytokines in human monocytic THP‐1 cells
Chi‐Hao Wu, Cheng‐Feng Wu, Hsiao‐Wen Huang, Ya‐Chien Jao and Gow‐Chin YenMolecular Nutrition & Food Research 53 (8) 984 (2009)
https://doi.org/10.1002/mnfr.200800495
Retinopatía diabética y ceguera en España. Epidemiología y prevención
Lluís Vila, Jaime Viguera and Ricardo AlemánEndocrinología y Nutrición 55 (10) 459 (2008)
https://doi.org/10.1016/S1575-0922(08)75843-1
Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls
Giancarlo Aldini, Isabella Dalle-Donne, Roberto Maffei Facino, Aldo Milzani and Marina CariniMedicinal Research Reviews 27 (6) 817 (2007)
https://doi.org/10.1002/med.20073
Molecular Action Mechanism against Apoptosis by Aqueous Extract from Guava Budding Leaves Elucidated with Human Umbilical Vein Endothelial Cell (HUVEC) Model
Chiu-Lan Hsieh, Chien-Ning Huang, Yuh-Charn Lin and Robert Y. PengJournal of Agricultural and Food Chemistry 55 (21) 8523 (2007)
https://doi.org/10.1021/jf071858b
Effects of flavonoids on the expression of the pro‐inflammatory response in human monocytes induced by ligation of the receptor for AGEs
Shang‐Ming Huang, Chi‐Hao Wu and Gow‐Chin YenMolecular Nutrition & Food Research 50 (12) 1129 (2006)
https://doi.org/10.1002/mnfr.200600075
Effect of pyridoxylidene aminoguanidine on human diploid cells B-HEF-2: In vitro cytotoxicity test and cytogenetic analysis
Ján Vojtaššák, Jozef Čársky, L’uboš Danišovič, et al.Toxicology in Vitro 20 (6) 868 (2006)
https://doi.org/10.1016/j.tiv.2005.12.009
Conclusions, perspectives et recommandations
D. Bonnefont-RousselotAnnales Pharmaceutiques Françaises 64 (6) 402 (2006)
https://doi.org/10.1016/S0003-4509(06)75336-6
Lipoxidation‐Derived Reactive Carbonyl Species as Potential Drug Targets in Preventing Protein Carbonylation and Related Cellular Dysfunction
Giancarlo Aldini, Isabella Dalle‐Donne, Roberto Colombo, Roberto Maffei Facino, Aldo Milzani and Marina CariniChemMedChem 1 (10) 1045 (2006)
https://doi.org/10.1002/cmdc.200600075
Diabète sucré, stress oxydant et produits de glycation avancée
D. Bonnefont-Rousselot, J.-L. Beaudeux, P. Thérond, J. Peynet, A. Legrand and J. DelattreAnnales Pharmaceutiques Françaises 62 (3) 147 (2004)
https://doi.org/10.1016/S0003-4509(04)94297-6
Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
Armando Rojas and Miguel A. MoralesLife Sciences 76 (7) 715 (2004)
https://doi.org/10.1016/j.lfs.2004.09.011
The Role of Antioxidant Micronutrients in the Prevention of Diabetic Complications
Dominique Bonnefont-RousselotTreatments in Endocrinology 3 (1) 41 (2004)
https://doi.org/10.2165/00024677-200403010-00005
Novel inhibitors of advanced glycation endproducts
Samuel Rahbar and James L FigarolaArchives of Biochemistry and Biophysics 419 (1) 63 (2003)
https://doi.org/10.1016/j.abb.2003.08.009
Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus
Paolo Men??, Francescaromana Festuccia and Francesco PuglieseAmerican Journal of Cardiovascular Drugs 3 (5) 315 (2003)
https://doi.org/10.2165/00129784-200303050-00002
Glucose and reactive oxygen species
Dominique Bonnefont-RousselotCurrent Opinion in Clinical Nutrition and Metabolic Care 5 (5) 561 (2002)
https://doi.org/10.1097/00075197-200209000-00016